Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al

Jean W. Liew, Elizabeth R. Graef, Jeffrey A. Sparks, Alfred Hyoungju Kim

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)E155
JournalAnnals of the Rheumatic Diseases
Issue number8
StatePublished - Aug 1 2022


  • antirheumatic agents
  • cardiovascular diseases
  • hydroxychloroquine

Cite this